Xylem (XYL) PT Raised to $56 at RBC Capital Following 4Q Report

February 3, 2017 6:48 AM

RBC Capital raised its price target on Xylem (NYSE: XYL) to $56.00 (from $55.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found